Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 312 (RNA5SP312) is a human processed pseudogene, derived from the 5S ribosomal RNA gene, and does not encode a functional protein[3][5]. It is transcribed as a non-coding RNA by RNA polymerase III, and clusters of these transcripts are upregulated in the liver and immune cells of patients with severe alcohol-associated hepatitis[2]. These pseudogene RNAs can interact with cytosolic nucleic acid sensors (such as RIG-I and ZBP1), triggering innate immune responses including type I interferon production and inflammatory cell death, thereby contributing to disease pathogenesis[2]. In general, processed pseudogenes, previously considered functionless, are now recognized to participate in diverse regulatory mechanisms, including acting as decoys (sponges) for microRNAs or RNA-binding proteins and modulating gene expression, and in disease can behave as DAMPs or participate in oncogenic/tumor-suppressive networks[7]. However, RNA5SP312 itself is not a therapeutic target, receptor, enzyme, or drug-interaction partner, but rather a genomic element with emerging importance in inflammatory diseases as a source of immunostimulatory RNA[2][3][5].
Not a druggable target; no direct mechanism of action for drugs described. Its transcripts activate innate immunity through nucleic acid sensors (ZBP1, RIG-I), leading to interferon responses and potentially cell death[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 312 (RNA5SP312).